01 · The Question
Is it acceptable for the organization paying for research to help decide what gets studied?
A funding agency announces a call for research on climate adaptation. A health foundation prioritizes maternal mortality. A pharmaceutical company funds evaluation of a treatment it developed. In each case, the funder has already influenced the research question before anyone collects a single observation.
Is that a conflict with scientific independence?
Not necessarily. Funding exists partly to direct resources toward particular problems. The more difficult issue is whether the funder helps establish legitimate research priorities or shapes the question so strongly that commercially, politically, or institutionally inconvenient possibilities are systematically excluded.
03 · What You Need to Know
Funding decisions shape what science gets done
Funders influence research even when they never edit a protocol
Research funding is selective. A funding agency defines priorities, issues calls, establishes eligibility rules, and decides which proposals receive resources. Projects outside those priorities may never be conducted, regardless of their scientific merit.
WHO explicitly recognizes that funders shape the future of health research through decisions about what receives support and how that support is provided. Its current clinical-trial guidance encourages funders to support research responsive to real-world health needs, including well-designed trials addressing unmet needs.
This kind of influence is not inherently problematic. Governments may prioritize neglected diseases. Charities may fund research related to their missions. Communities may identify questions important to them. Companies understandably study products they are developing.
The existence of a funding priority therefore tells you that resources have been directed toward a question. It does not by itself establish inappropriate interference.
Priority-setting and sponsor control are different
A useful distinction is between defining the problem worth studying and manipulating the question to favor a desired answer.
Legitimate priority-setting
A funder identifies a problem, population, intervention, policy need, or broad research area it is willing to support while allowing scientifically defensible questions and methods to be developed.
Problematic sponsor control
A funder uses its financial leverage to require a question or comparison structured primarily to protect its interests, suppress meaningful alternatives, or prevent investigators from exercising appropriate scientific judgment.
The boundary can be contextual. A sponsor may have sound scientific reasons for requesting a particular question. The fact that the answer could also benefit the sponsor does not automatically make the question illegitimate.
The framing of a question can shape the answer a study is capable of producing
A research question determines what evidence will be generated. Small differences in framing can therefore have large consequences.
Suppose a company develops a new treatment. Asking whether the treatment works better than placebo addresses one question. Asking whether it performs better than the current standard treatment addresses another. Asking about short-term symptom improvement differs from asking about long-term clinical outcomes.
None of these questions is automatically wrong. A placebo-controlled study may be scientifically and ethically appropriate in some circumstances. But if a sponsor consistently chooses questions that avoid meaningful comparisons, the resulting evidence may be technically valid while still being less informative for the decisions patients, clinicians, policymakers, or other users actually face.
A funder may legitimately propose a specific question
There is no general rule requiring research questions to originate solely in an investigator's mind. Research can be commissioned precisely because someone needs an answer.
A government department may ask whether a program works. A foundation may commission research on an underserved population. A company may need evidence about the safety or effectiveness of a product. Patient organizations may identify outcomes that researchers have historically neglected.
The source of the question is therefore less important than its scientific and ethical defensibility.
Researchers should be able to ask whether the proposed question addresses a genuine knowledge need, whether the design can answer it, whether relevant alternatives are being omitted without justification, and whether the sponsor permits honest reporting regardless of the answer.
Commercial relevance does not make a research question scientifically illegitimate
A question can simultaneously serve scientific and commercial purposes. Testing whether a new product is safe and effective may be scientifically important even though favorable findings could benefit its manufacturer.
The conflict-of-interest concern comes from the sponsor's stake in the outcome and the opportunities that stake creates for influence. It does not logically follow that the question itself is invalid.
This distinction is part of the broader issue of when research funding creates a conflict of interest. The sponsor's interests should be transparent, while the research question should still be evaluated on its scientific merits.
Research agendas can be influenced through omission as well as direct control
Funders influence science not only by specifying what researchers must study but also by deciding what they will not support.
A commercial sponsor may have little incentive to fund head-to-head comparisons that could show a competitor's product performs better. A government may prioritize certain policy questions over others. A disease-focused charity may understandably concentrate on its own constituency.
No individual funder is necessarily obliged to finance every scientifically worthwhile question. Yet across an entire research ecosystem, funding priorities can leave important evidence gaps.
This means that the absence of evidence on a question should not automatically be interpreted as evidence that researchers considered the question unimportant. Sometimes the question simply attracted less funding.
Who helped formulate the question should be transparent
ICMJE recommends that published articles identify their sources of support and explain the sponsor's role, if any, in study design, data collection, analysis and interpretation, report writing, and restrictions concerning publication. It also recommends reporting whether authors had access to the study data.
These disclosures help readers distinguish an investigator-designed study supported financially by a company from a sponsor-designed study conducted by outside investigators. Both may produce useful evidence, but they represent different research relationships.
Funder involvement should not remove investigators' scientific responsibility
Even when a sponsor proposes the research question, investigators remain responsible for the scientific work they agree to conduct and publish.
A researcher should not defend a weak or misleading question simply by saying, “The funder wanted it.” If the question cannot produce meaningful evidence, uses an inappropriate comparison, creates avoidable ethical concerns, or is presented in a misleading way, investigators retain professional responsibilities for their participation.
Funding does not outsource scientific judgment.
Stakeholder involvement can improve research questions
Not all external influence should be treated suspiciously. WHO's current clinical-trial work explicitly encourages research that responds to real-world needs and incorporates public and community engagement.
Patients, practitioners, communities, policymakers, industry specialists, and other stakeholders may identify questions that academic researchers have overlooked. The goal is therefore not investigator isolation. It is transparent collaboration in which financial or institutional power does not override scientific and ethical judgment.
The research question is only the first point at which sponsor influence can operate
A scientifically reasonable question can still be investigated poorly. Conversely, a sponsor may have little role in choosing the question but substantial control over the methods, analysis, data, or publication.
For that reason, evaluating sponsor influence should not stop after establishing who proposed the study. The next question is who controls the methods and analysis.
04 · A Practical Example
How the sponsor can shape a study before recruitment begins
Hypothetical Example
A company wants evidence about a new learning platform
A company funds university researchers to evaluate its new digital learning platform. The company initially proposes the question, “Does using the platform improve student achievement compared with receiving no additional digital support?” The researchers point out that most schools already use another established platform, making comparison with usual practice or an active alternative potentially more useful.
Legitimate sponsor interest
The company reasonably wants evidence about whether its product works and provides funding to answer that question.
Scientific judgment
The researchers assess whether the proposed comparison answers a meaningful question for actual educational decision-making.
Negotiation
Researchers and sponsor discuss a comparator and outcomes capable of producing scientifically useful evidence rather than merely the easiest favorable comparison.
Transparency
The publication accurately reports the company's financial support and role in study design.
Independence
The researchers retain responsibility for the scientific defensibility of the final protocol and for reporting the results regardless of whether they favor the platform.
The sponsor's involvement in formulating the question is not automatically unethical. The critical issue is whether financial leverage prevents researchers from asking a scientifically meaningful question or reporting an inconvenient answer.
07 · A Quick Checklist
What should you check when a funder helps shape the research question?
Before accepting a sponsor-defined research question, check:
Identify the funder's financial, policy, institutional, advocacy, or other interests in the possible findings.
Ask whether the question addresses a genuine scientific, clinical, social, policy, or practical knowledge need.
Check whether the proposed comparator and outcomes allow a meaningful answer rather than merely a convenient favorable comparison.
Consider important questions or alternatives excluded by the proposed framing and whether those exclusions are scientifically justified.
Clarify which aspects of study design remain under investigator control.
Ensure that the agreement permits honest reporting even if the answer is unfavorable to the funder.
Disclose the source of support and the funder's role in study design according to applicable journal and institutional requirements.
Do not accept a scientifically indefensible question merely because funding depends on it.
